Prelude Therapeutics Inc (PRLD): SC 13G/A filed Feb 12, 2024

Form type

SC 13G/A

Filing date

Feb 12, 2024

Accession number

0001193125-24-032116

Filer

Prelude Therapeutics Inc (CIK 1678660)